Search Results 511-520 of 17054 for Quarantine

  1. A Study of the Effectiveness and Safety of Rivaroxaban on Venous Thromboembolic Risk in Patients Following Hospital Discharge - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  2. The EMPrint™ Ablate and RESect Study in Patients With Metastatic Lung Tumors - Mayo Clinic

    Post market prospective, non-randomized, single-arm, multicenter study, designed to demonstrate dose response of an ablation system using a percutaneous ...

  3. A Study of Immune Response to the Human Papillomavirus Vaccine in Young Women with Inflammatory Bowel Disease - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  4. Photomicrographs of CRS specimens stained with Hematoxylin & Eosin (left) or stained for eosinophil major basic protein (MBP) by immunofluorescence (right).

  5. A Study to Evaluate and Monitor Hepatitis Activity in Hepatitis C Virus Infection Patients Using Advanced Multiparametric MR Elastography (MRE) - Mayo Clinic

    The purpose of this study is to develop an advanced multiparametric liver magnetic resonance elastography (MRE) imaging technology for monitoring hepatic ...

  6. A Study of AK002 in Patients with Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis - Mayo Clinic

    It is hypothesized that AK002 is more effective than placebo control (alternative hypothesis) in reducing the number of eosinophils per high power field (HPF) ...

  7. A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower130) - Mayo Clinic

    Clinical Trials · A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With ...

  8. Phase I/II Cancer Caregiver Interventions to Improve Quality of Life and Prevent Burnout - Mayo Clinic

    This study defines cancer caregivers as unpaid individuals who provide physical, practical, and/or emotional care and support to the cancer patient in the home ...

  9. Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver Undergoing Surgery - Mayo Clinic

    About this study. This pilot clinical trial studies the best dose of erlotinib hydrochloride and to see how well it works in preventing liver cancer in ...

  10. A Clinical Study Of KTX-2001 In Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

    Study K36-MCRPC-001 is the first in human clinical trial testing KTX-2001 alone and with darolutamide in men with metastatic castration-resistant prostate ...